Maintaining bone health by estrogen therapy in patients with advanced prostate cancer: a narrative review

The purpose of androgen deprivation therapy (ADT) in prostate cancer (PCa), using luteinizing hormone-releasing hormone agonists (LHRHa) or gonadotrophin-releasing hormone antagonists, is to suppress the levels of testosterone. Since testosterone is the precursor of estradiol (E2), one of the major...

Descripción completa

Detalles Bibliográficos
Autores principales: Coelingh Bennink, Herjan J T, Krijgh, Jan, Egberts, Jan F M, Slootweg, Maria, van Melick, Harm H E, Roos, Erik P M, Somford, Diederik M, Zimmerman, Yvette, Schultz, Iman J, Clarke, Noel W, van Moorselaar, R Jeroen A, Debruyne, Frans M J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716371/
https://www.ncbi.nlm.nih.gov/pubmed/36283120
http://dx.doi.org/10.1530/EC-22-0182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716371/
https://www.ncbi.nlm.nih.gov/pubmed/36283120
http://dx.doi.org/10.1530/EC-22-0182

Ejemplares similares